On 15 and 16 March, partners from the FACILITATE consortium will gather at Eurac. FACILITATE is a 4-year project launched by the Innovative Medicines Initiative (IMI) which primary aim is to enable clinical trial participants to access and make use of their personal health data gathered during studies, to allow a better shared medical decision-making with the health professionals involved in their care and to create a process that allows data to be re-used also in future research.

Its overall goal is to develop an innovative data-sharing and re-use process within a General Data Protection Regulation (GDPR) compliant and approved ethical framework, not only to allow the access and portability of patient data but also to change the role of patients in the strategy and design of clinical trials – with many new rights and responsibilities – becoming an active component of the drug development process.

Our institute for Biomedicine is workpackage leader tasked with developing the ethical frameworks on return of clinical trial data and secondary reuse of clinical trial data.

At the meeting on 15 and 16 March, partners will gather to discuss key elements of the developing ethical frameworks.